https://www.selleckchem.com/pr....oducts/prt062607-p50
Non-selective β-blockers (NSB are frequently used for the treatment of portal hypertension and gastroesophageal varices in patients with liver cirrhosis; however prospective studies investigating the potential association between NSBB use and hepatic encephalopathy (HE) are still scarce. We investigated the potential association between NSBB use and the presence of covert HE (CHE) as well as the development of overt HE (OHE). 224 patients with liver cirrhosis were included into this cohort study at two German centers and
Like
Comment
Share
